Last 12 months
Inside the activity.
2 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2021 Filed Nov 12, 2021 23:01 UTC |
Bilbo PatrickChief Operating Officer
|
Exercise / conversionClass A Common Stock | 30,450 | $1.44 | $43,848.00 |
DisclosureSEC source: 0001661181-21-000068 · edgar.xml · nonDerivative · entry 1 Bilbo Patrick · CIK 0001759203 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The reporting person transferred 60,900 shares of Class A Common Stock held by the reporting person to his former spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his former spouse. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 19:38 UTC |
KATZ MICHAEL W10% owner
|
PurchaseClass A Common Stock | 12,000 | $13.55 | $162,600.00 |
DisclosureSEC source: 0001661181-21-000066 · edgar.xml · nonDerivative · entry 1 KATZ MICHAEL W · CIK 0001279930 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,282 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $13.34 to $13.68, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 18:23 UTC |
Leibowitz Arthur SDirector
|
GrantClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000064 · edgar.xml · nonDerivative · entry 1 Leibowitz Arthur S · CIK 0001467329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,307 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on August 3, 2022. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 160,237 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · derivative · entry 9 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,860 Underlying: Class A Common Stock · 160,237 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
SaleClass A Common Stock | 160,237 | $14.02 | $2,246,522.74 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · nonDerivative · entry 6 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,917 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021. F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.61 to $14.38, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
Exercise / conversionClass A Common Stock | 160,237 | $0.99 | $158,634.63 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · nonDerivative · entry 5 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 115,450 | $0.00 Strike: $4.04 | $0.00 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · derivative · entry 8 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,392 Underlying: Class A Common Stock · 115,450 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option became and continues to become exercisable in equal annual installments over four years beginning April 1, 2020. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,313 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · derivative · entry 7 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680,097 Underlying: Class A Common Stock · 24,313 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
SaleClass A Common Stock | 29,434 | $15.33 | $451,223.22 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · nonDerivative · entry 4 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,917 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021. F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.85, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
SaleClass A Common Stock | 110,329 | $14.58 | $1,608,596.82 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · nonDerivative · entry 3 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,351 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.27 to $14.99, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
Exercise / conversionClass A Common Stock | 115,450 | $4.04 | $466,418.00 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · nonDerivative · entry 2 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 00:45 UTC |
Gillheeney Gary S.Director · President and CEO
|
Exercise / conversionClass A Common Stock | 24,313 | $0.99 | $24,069.87 |
DisclosureSEC source: 0001661181-21-000062 · edgar.xml · nonDerivative · entry 1 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 21:33 UTC |
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
SaleClass A Common Stock | 150,000 | $15.31 | $2,296,500.00 |
DisclosureSEC source: 0001661181-21-000058 · edgar.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,432,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.63, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 21:27 UTC |
Ades Alan A.Director · 10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
NUSSDORF GLENN HDirector · 10% owner
|
SaleClass A Common Stock | 150,000 | $15.31 | $2,296,500.00 |
DisclosureSEC source: 0001661181-21-000056 · edgar.xml · nonDerivative · entry 1 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,432,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.63, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 08, 2021 Filed Jun 8, 2021 20:03 UTC |
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
SaleClass A Common Stock | 100,000 | $15.41 | $1,541,000.00 |
DisclosureSEC source: 0001661181-21-000054 · edgar.xml · nonDerivative · entry 3 ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,582,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $16.05, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 08, 2021 Filed Jun 8, 2021 19:52 UTC |
Ades Alan A.Director · 10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
NUSSDORF GLENN HDirector · 10% owner
|
SaleClass A Common Stock | 100,000 | $15.41 | $1,541,000.00 |
DisclosureSEC source: 0001661181-21-000053 · edgar.xml · nonDerivative · entry 3 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,582,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $16.05, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:03 UTC |
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
SaleClass A Common Stock | 94,612 | $16.14 | $1,527,037.68 |
DisclosureSEC source: 0001661181-21-000054 · edgar.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,682,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:52 UTC |
Ades Alan A.Director · 10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
NUSSDORF GLENN HDirector · 10% owner
|
SaleClass A Common Stock | 94,612 | $16.14 | $1,527,037.68 |
DisclosureSEC source: 0001661181-21-000053 · edgar.xml · nonDerivative · entry 2 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,682,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:03 UTC |
ERANI ALBERT10% owner
Wisdom Starr10% owner
|
SaleClass A Common Stock | 60,000 | $16.22 | $973,200.00 |
DisclosureSEC source: 0001661181-21-000054 · edgar.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,776,745 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.30, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 19:52 UTC |
Ades Alan A.Director · 10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
NUSSDORF GLENN HDirector · 10% owner
|
SaleClass A Common Stock | 60,000 | $16.22 | $973,200.00 |
DisclosureSEC source: 0001661181-21-000053 · edgar.xml · nonDerivative · entry 1 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,776,745 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.30, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| May 27, 2021 Filed May 28, 2021 21:32 UTC |
Ades Alan A.Director · 10% owner
ERANI ALBERT10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
|
SaleClass A Common Stock | 3,887,500 | $16.40 | $63,755,000.00 |
DisclosureSEC source: 0001661181-21-000049 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,836,745 F1 · shares: The reported securities sold were held directly by the Alan Ades 2014 GRAT, which is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Alan A. Ades and the Alan Ades 2014 GRAT. F2 · price: The sale was executed in a single block trade at $16.40 per share. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| May 27, 2021 Filed May 28, 2021 21:37 UTC |
NUSSDORF GLENN HDirector · 10% owner
Wisdom Starr10% owner
|
SaleClass A Common Stock | 3,887,500 | $16.40 | $63,755,000.00 |
DisclosureSEC source: 0001661181-21-000050 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,836,745 F1 · shares: The reported securities sold were held directly by the Alan Ades 2014 GRAT, which is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Alan A. Ades and the Alan Ades 2014 GRAT. F2 · price: The sale was executed in a single block trade at $16.40 per share. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| May 27, 2021 Filed Jun 29, 2021 01:17 UTC |
Erani Dennis10% owner
|
SaleClass A Common Stock | 9,106 | $18.97 | $172,740.82 |
DisclosureSEC source: 0001661181-21-000060 · edgar.xml · nonDerivative · entry 1 Erani Dennis · CIK 0001760685 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,314,517 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.90 to $19.21, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:45 UTC |
Avista Capital Managing Member IV, LLCDirector · 10% owner
Avista Acquisition Corp.Director · 10% owner
Avista Acquisition, LLCDirector · 10% owner
Avista Capital Partners IV, L.P.Director · 10% owner
Avista Capital Partners (Offshore) IV, L.P.Director · 10% owner
Avista Capital Partners IV GP, L.P.Director · 10% owner
Dean ThompsonDirector · 10% owner
Burgstahler David FDirector · 10% owner
|
OtherClass A common stock | 21,154,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017951 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 7,721,298 F2 · shares: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution"). F3 · shares: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution. F2 · price: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution"). F3 · balance_after: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| May 07, 2021 Filed May 11, 2021 21:52 UTC |
Giacomin Jon LDirector
|
GrantClass A Common Stock | 5,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000044 · edgar.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,319 F1 · kind: Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over three years beginning May 7, 2021. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC |
Ades Alan A.Director · 10% owner
ERANI ALBERT10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
|
OtherClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 6 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,724,507 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F7 · shares: The reported securities were distributed by Organo PFG LLC to Dennis Erani as Trustee of the Dennis Erani 2014 GRAT. Dennis Erani is a member of the Group (as defined below). Dennis Erani disclaims beneficial ownership of the Shares held by the Dennis Erani 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC |
Ades Alan A.Director · 10% owner
ERANI ALBERT10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
|
OtherClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 5 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,306,607 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F6 · shares: The reported securities were distributed by Organo PFG LLC to Albert Erani as Trustee of the Albert Erani 2014 GRAT. Albert Erani is a member of the Group (as defined below). Albert Erani disclaims beneficial ownership of the Shares held by the Albert Erani 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC |
Ades Alan A.Director · 10% owner
ERANI ALBERT10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
|
OtherClass A Common Stock | 115,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 4 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,645,478 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F5 · shares: The reported securities were distributed by Organo PFG LLC to Albert Erani, who is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC |
Ades Alan A.Director · 10% owner
ERANI ALBERT10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
|
OtherClass A Common Stock | 9,235,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,529,793 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F4 · shares: The reported securities were distributed by Organo PFG LLC to Alan A. Ades as Trustee of the Alan Ades 2014 GRAT, which is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC |
Ades Alan A.Director · 10% owner
ERANI ALBERT10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
|
OtherClass A Common Stock | 120,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,294,298 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F3 · shares: The reported securities were distributed by Organo PFG LLC to Alan A. Ades, who is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC |
Ades Alan A.Director · 10% owner
ERANI ALBERT10% owner
Erani Dennis10% owner
Organo PFG LLC10% owner
Organo Investors LLC10% owner
Alan Ades 2014 GRAT10% owner
|
OtherClass A Common Stock | 23,855,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,173,793 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F2 · shares: The reported securities were distributed by Organo PFG LLC, which is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:56 UTC |
NUSSDORF GLENN HDirector · 10% owner
Wisdom Starr10% owner
|
OtherClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000040 · edgar.xml · nonDerivative · entry 6 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,724,507 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F7 · shares: The reported securities were distributed by Organo PFG LLC to Dennis Erani as Trustee of the Dennis Erani 2014 GRAT. Dennis Erani is a member of the Group (as defined below). Dennis Erani disclaims beneficial ownership of the Shares held by the Dennis Erani 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:56 UTC |
NUSSDORF GLENN HDirector · 10% owner
Wisdom Starr10% owner
|
OtherClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000040 · edgar.xml · nonDerivative · entry 5 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,306,607 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F6 · shares: The reported securities were distributed by Organo PFG LLC to Albert Erani as Trustee of the Albert Erani 2014 GRAT. Albert Erani is a member of the Group (as defined below). Albert Erani disclaims beneficial ownership of the Shares held by the Albert Erani 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:56 UTC |
NUSSDORF GLENN HDirector · 10% owner
Wisdom Starr10% owner
|
OtherClass A Common Stock | 115,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000040 · edgar.xml · nonDerivative · entry 4 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,645,478 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F5 · shares: The reported securities were distributed by Organo PFG LLC to Albert Erani, who is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:56 UTC |
NUSSDORF GLENN HDirector · 10% owner
Wisdom Starr10% owner
|
OtherClass A Common Stock | 9,235,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000040 · edgar.xml · nonDerivative · entry 3 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,529,793 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F4 · shares: The reported securities were distributed by Organo PFG LLC to Alan A. Ades as Trustee of the Alan Ades 2014 GRAT, which is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:56 UTC |
NUSSDORF GLENN HDirector · 10% owner
Wisdom Starr10% owner
|
OtherClass A Common Stock | 120,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000040 · edgar.xml · nonDerivative · entry 2 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,294,298 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F3 · shares: The reported securities were distributed by Organo PFG LLC to Alan A. Ades, who is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:56 UTC |
NUSSDORF GLENN HDirector · 10% owner
Wisdom Starr10% owner
|
OtherClass A Common Stock | 23,855,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000040 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,173,793 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F2 · shares: The reported securities were distributed by Organo PFG LLC, which is a member of the Group (as defined below). Read SEC document |
| April 09, 2021 Filed May 18, 2021 23:45 UTC |
Wisdom Starr10% owner
|
SaleClass A Common Stock | 20,000 | $22.11 | $442,200.00 |
DisclosureSEC source: 0001661181-21-000046 · edgar.xml · nonDerivative · entry 11 Wisdom Starr · CIK 0001760694 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:43 UTC |
Montecalvo Antonio S.VP Health Policy & Contracting
|
Tax withholdingClass A Common Stock | 1,770 | $19.83 | $35,099.10 |
DisclosureSEC source: 0000899243-21-014956 · doc4.xml · nonDerivative · entry 1 Montecalvo Antonio S. · CIK 0001759261 · VP Health Policy & Contracting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,556 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:46 UTC |
Freedman LoriVP and General Counsel
|
Tax withholdingClass A Common Stock | 1,975 | $19.83 | $39,164.25 |
DisclosureSEC source: 0000899243-21-014959 · doc4.xml · nonDerivative · entry 1 Freedman Lori · CIK 0001410291 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,751 Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:49 UTC |
Grow BrianChief Commercial Officer
|
Tax withholdingClass A Common Stock | 1,977 | $19.83 | $39,203.91 |
DisclosureSEC source: 0000899243-21-014962 · doc4.xml · nonDerivative · entry 1 Grow Brian · CIK 0001759142 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,572 Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:43 UTC |
Gillheeney Gary S.Director · President and CEO
|
Tax withholdingClass A Common Stock | 6,265 | $19.83 | $124,234.95 |
DisclosureSEC source: 0000899243-21-014957 · doc4.xml · nonDerivative · entry 1 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,542 Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:47 UTC |
Bilbo PatrickChief Operating Officer
|
Tax withholdingClass A Common Stock | 2,497 | $19.83 | $49,515.51 |
DisclosureSEC source: 0000899243-21-014960 · doc4.xml · nonDerivative · entry 1 Bilbo Patrick · CIK 0001759203 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,120 Read SEC document |
| April 01, 2021 Filed Apr 9, 2021 00:34 UTC Amendment |
Gillheeney Gary S.Director · President and CEO
|
Tax withholdingClass A Common Stock | 7,890 | $19.83 | $156,458.70 |
DisclosureSEC source: 0000899243-21-015444 · doc4a.xml · nonDerivative · entry 1 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,917 F1 · shares: This Form 4/A is being filed to correct an administrative error in the reported number of securities forfeited for tax witholding purposes and the amount of securities beneficially owned following the transaction. F1 · balance_after: This Form 4/A is being filed to correct an administrative error in the reported number of securities forfeited for tax witholding purposes and the amount of securities beneficially owned following the transaction. Read SEC document |
| March 01, 2021 Filed May 18, 2021 23:45 UTC |
Wisdom Starr10% owner
|
SaleClass A Common Stock | 8,050 | $16.50 | $132,825.00 |
DisclosureSEC source: 0001661181-21-000046 · edgar.xml · nonDerivative · entry 10 Wisdom Starr · CIK 0001760694 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| February 25, 2021 Filed May 18, 2021 23:45 UTC |
Wisdom Starr10% owner
|
SaleClass A Common Stock | 1,950 | $16.50 | $32,175.00 |
DisclosureSEC source: 0001661181-21-000046 · edgar.xml · nonDerivative · entry 9 Wisdom Starr · CIK 0001760694 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,050 Read SEC document |
| February 25, 2021 Filed May 18, 2021 23:45 UTC |
Wisdom Starr10% owner
|
SaleClass A Common Stock | 27,385 | $14.71 | $402,833.35 |
DisclosureSEC source: 0001661181-21-000046 · edgar.xml · nonDerivative · entry 8 Wisdom Starr · CIK 0001760694 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| February 24, 2021 Filed May 18, 2021 23:45 UTC |
Wisdom Starr10% owner
|
SaleClass A Common Stock | 15,154 | $14.70 | $222,763.80 |
DisclosureSEC source: 0001661181-21-000046 · edgar.xml · nonDerivative · entry 7 Wisdom Starr · CIK 0001760694 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,385 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 01:34 UTC |
Gillheeney Gary S.Director · President and CEO
|
SaleClass A Common Stock | 16,663 | $12.85 | $214,119.55 |
DisclosureSEC source: 0001661181-21-000025 · edgar.xml · nonDerivative · entry 4 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,807 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2020. F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.62 to $13.265, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 01:34 UTC |
Gillheeney Gary S.Director · President and CEO
|
SaleClass A Common Stock | 11,174 | $13.82 | $154,424.68 |
DisclosureSEC source: 0001661181-21-000025 · edgar.xml · nonDerivative · entry 3 Gillheeney Gary S. · CIK 0001757373 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,470 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2020. F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.76 to $13.90, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.